CCR5 and infective vaginitis: While a recent study had shown the efficacy of maraviroc in preventing vaginal infection in rhesus macaques by a CCR-5 using SHIV-162P3 hybrid virus [28], our present results demonstrated the efficacy of the drug against HIV-1 in a human target cell context in humanized mice.